Additionally, the risk score was significantly increased in samples with the molecular characteristics of IDH-wildtype, chromosome 1p/19q non-codeleted and MGMT promoter unmethylated, which were generally thought to drive the malignant progression of glioma (supplementary Fig. 4). This evidence concerns the gene IDH1 and central nervous system cancer.